Literature DB >> 35989831

Impact of Non-viral Coinfections on Mortality of Severely Ill COVID-19 Patients in Dubai.

Rashid Nadeem1, Aju Rafeeq2, Anas A Aga2, Ayesha Siddiqua2, Ekta Sharma3, Doaa Anwer4, Mohd Kafeel Khan5, Mohamed Abdulla Mohammed Hussein5, Yusra Omar Alshaikh SayedAhmed6, Farooq Ahmad Dar7.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) infections may have been associated with secondary infection. Community-acquired or hospital-acquired such infections affect clinical outcomes. We performed a retrospective study to evaluate the impact of these infections on clinical outcomes.
METHODS: This was a retrospective analysis of all consecutive patients with COVID-19 admitted to the intensive care unit (ICU) of Dubai hospital.
RESULTS: Patients with secondary non-viral infections (SNIs) have higher mortality than patients without SNIs (57.3% vs. 43.7%, p=0.037). Patients with SNIs had more days on mechanical ventilation (MV) 19(11-27) vs. 5(2-10) p<0.001, more LOSICU 22 (15-33) vs. 7 (2-11) p<0.001, and more length of stay in hospital (LOSH) 28 (18-45) vs. 11.5 (6-19), p<0.001. Multiple logistic regression analyses showed that SNIs do not predict mortality. Linear logistic regression analysis showed patients with SNIs have increased length of stay in ICUs (LOSICUs), length of stay in hospitals (LOSHs), and prolonged needs for MV.
CONCLUSION: SNIs are high in patients admitted to ICU for COVID-19 acute respiratory distress syndrome (ARDS). Although they do not impact mortality, they prolong the need for MV, LOSICU, and LOSH.
Copyright © 2022, Nadeem et al.

Entities:  

Keywords:  covid-19; length of stay in icu; length of stay in the hospital; mortality; secondary bacterial infection

Year:  2022        PMID: 35989831      PMCID: PMC9385072          DOI: 10.7759/cureus.26977

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  22 in total

1.  Clinical features predicting mortality risk in older patients with COVID-19.

Authors:  Jing Zhou; Lili Huang; Jin Chen; Xiaowei Yuan; Qinhua Shen; Su Dong; Bei Cheng; Tang-Meng Guo
Journal:  Curr Med Res Opin       Date:  2020-10-12       Impact factor: 2.580

2.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-01-12       Impact factor: 17.440

Review 4.  Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients.

Authors:  A Ferro; S Kotecha; G Auzinger; E Yeung; K Fan
Journal:  Br J Oral Maxillofac Surg       Date:  2021-05-18       Impact factor: 1.651

5.  Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience.

Authors:  Sonam Vijay; Nitin Bansal; Brijendra Kumar Rao; Balaji Veeraraghavan; Camilla Rodrigues; Chand Wattal; Jagdish Prasad Goyal; Karuna Tadepalli; Purva Mathur; Ramanathan Venkateswaran; Ramasubramanian Venkatasubramanian; Sagar Khadanga; Sanjay Bhattacharya; Sudipta Mukherjee; Sujata Baveja; Sujatha Sistla; Samiran Panda; Kamini Walia
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

6.  SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?

Authors:  Jose A Bengoechea; Connor Gg Bamford
Journal:  EMBO Mol Med       Date:  2020-06-15       Impact factor: 14.260

7.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

8.  COVID-19-associated invasive pulmonary aspergillosis.

Authors:  Lynn Rutsaert; Nicky Steinfort; Tine Van Hunsel; Peter Bomans; Reinout Naesens; Helena Mertes; Hilde Dits; Niels Van Regenmortel
Journal:  Ann Intensive Care       Date:  2020-06-01       Impact factor: 6.925

9.  Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.

Authors:  Syed Shahzad Hasan; Toby Capstick; Raees Ahmed; Chia Siang Kow; Faizan Mazhar; Hamid A Merchant; Syed Tabish Razi Zaidi
Journal:  Expert Rev Respir Med       Date:  2020-09-29       Impact factor: 3.772

10.  Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.

Authors:  Sara Y Tartof; Lei Qian; Vennis Hong; Rong Wei; Ron F Nadjafi; Heidi Fischer; Zhuoxin Li; Sally F Shaw; Susan L Caparosa; Claudia L Nau; Tanmai Saxena; Gunter K Rieg; Bradley K Ackerson; Adam L Sharp; Jacek Skarbinski; Tej K Naik; Sameer B Murali
Journal:  Ann Intern Med       Date:  2020-08-12       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.